| |
|
|
|
|
|
|
|||
|
Blood, 1 March 2008, Vol. 111, No. 5, pp. 2806-2815. Prepublished online as a Blood First Edition Paper on December 3, 2007; DOI 10.1182/blood-2007-04-085555.
Submitted April 17, 2007
Department of Internal Medicine, Research Center for Experimental Medicine (CeRMS), and Center for Molecular Biotechnology, University of Torino, Torino, Italy * Corresponding author; email: ddl{at}unife.it.
Human Herpesvirus 8 (HHV-8) is considered the primary etiologic agent of Kaposi's sarcoma (KS) and HHV-8 infected endothelial cells acquire a KS-like phenotype.
In the present study we evaluated whether infection of microvascular endothelial cells (HMEC) with HHV-8 can trigger the expression of PAX2 oncogene and whether Pax2 protein is involved in HHV-8-induced transformation of HMEC. We found that HHV-8 infection induced the expression of both the PAX2 gene and Pax2 protein in HMEC but failed to induce Pax2 protein in HMEC stably transfected with PAX2 antisense (HMEC-AS). HHV-8-infected HMEC but not HMEC-AS acquired proinvasive proadhesive properties, enhanced survival and in vitro angiogenesis suggesting a correlation between Pax2 expression and the effects triggered by HHV-8 infection. When HMEC expressing Pax2 by stable transfection with PAX2 sense gene or by HHV-8 infection were implanted in vivo in SCID mice, enhanced angiogenesis and proliferative lesions resembling KS were observed. HHV-8 infected HMEC-AS failed to induce angiogenesis and KS-like lesions. These results suggest that the expression of Pax2 is required for the proangiogenic and proinvasive changes induced by HHV-8 infection in HMEC. In conclusion, HHV-8 infection may activate an embryonic angiogenic program in HMEC by inducing the expression of PAX2 oncogene.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2007 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||